About Negev Capital
Negev Capital is a Healthcare company based in Cayman Islands founded in 2021. Venture capital fund investing in psychedelic health startups globally for innovation. It operates on a B2B model in Healthcare and Financial Services sectors. Negev Capital offers products and services including Investment Services and Portfolio Management. Its focus areas include Health Tech, Psychedelic Medicine, Mental Health Innovation and Clinical Development.
Company details
Negev Capital operates as an investment fund with over 30 million, targeting early-stage companies in psychedelic medicine. It provides funding from 500,000 to 2 million per deal, focusing on preclinical or Phase I clinical development. Based in the Cayman Islands, the fund supports portfolio firms like Beckley Psytech and Mindset Pharma through strategic advice and risk analysis, targeting regions including USA, Canada, EU, and Israel.
- Headquarters Cayman Islands
- SectorsHealthcareFinancial Services
- Website negevcap.com
- Legal Name Negev Capital
Products & Services of Negev Capital
Negev Capital offers a comprehensive portfolio of products and services, including Investment Services and Portfolio Management.
Provides funding and strategic support to psychedelic startups.
Offers risk analysis and business guidance for health firms.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Negev Capital
Complete news archive for Negev Capital
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Negev Capital
Negev Capital was founded in 2021.
Negev Capital is headquartered in Cayman Islands.
Negev Capital operates as an investment fund with over 30 million, targeting early-stage companies in psychedelic medicine. It provides funding from 500,000 to 2 million per deal, focusing on preclinical or Phase I clinical development. Based in the Cayman Islands, the fund supports portfolio firms like Beckley Psytech and Mindset Pharma through strategic advice and risk analysis, targeting regions including USA, Canada, EU, and Israel.
Negev Capital offers Investment Services and Portfolio Management.
Negev Capital operates through Negev Capital.